Dr Mark Kellett

Consultant Neurologist

MBBS, B.Med.Sci(Hons), MD FRCP

Professional Membership

  • British Medical Association

  • Fellow of Royal College of Physicians (London)

  • Association of British Neurologists

  • Movement Disorders Society

Clinical Interests

  • General / Emergency Neurology

  • Headache and migraine

  • Investigation of Weakness or sensory disturbance

  • Epilepsy and Blackouts

  • Multiple sclerosis including prescribing of Fampiridine

  • Movement disorders

  • Parkinson’s disease

  • Dystonia

  • Botulinum toxin treatment for various types of dystonia, tics and hemifacial spasm.

  • Botox for chronic migraine.



Personal profile

Dr Kellett qualified from Newcastle Upon Tyne University in 1991. After junior doctor posts in Newcastle upon Tyne and Middlesbrough he took up his specialist registrar training at the Walton Centre for Neurology and Neurosurgery in Liverpool. He became a member of the Royal College of Physicians in 1994 and a Fellow in 2003. During his registrar training he completed a Doctorate of Medicine (MD) on the genetics of Parkinson’s disease and developed a subspecialist interest in movement disorders and Parkinson’s disease. He was appointed to the GMC specialist register for neurology in 2000.

He was appointed Consultant Neurologist at Hope Hospital (now Salford Royal NHS Foundation Trust) in 2000. He provides a general neurology service and specialist clinics in movement disorders, botulinum toxin treatment and Botox for Chronic Migraine. In 2013 he joined the Nationally commissioned Neurofibromatosis Type 2 services based at St Mary’s Hospital, Manchester as Consultant Neurologist in addition to continuing at Salford Royal. He commenced his private practice in 2000 and has extensive experience in movement disorders, Parkinson’s disease, assessment for movement disorders surgery, epilepsy, headaches, multiple sclerosis and the investigation of emergency neurological disorders. He is an approved provider of Botox for Chronic Migraine and has lectured on it’s use nationally.

In 2007 he was made clinical director of the neurology department at Greater Manchester Neurosciences Centre, based at Salford Royal Hospital and in 2002 was appointed as Clinical Director of Medical Neurosciences covering; Neurology, stroke services, neurorehabilitation, neurophysiology and neuropsychology.

He is the Greater Manchester, Lancashire and South Cumbria Senate representative on the national specialist commissioning clinical reference group for neurological disorders and the Clinical Lead of the Strategic clinical network for neurological disorders.

Year qualified: